[go: up one dir, main page]

NO20055137D0 - Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer - Google Patents

Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer

Info

Publication number
NO20055137D0
NO20055137D0 NO20055137A NO20055137A NO20055137D0 NO 20055137 D0 NO20055137 D0 NO 20055137D0 NO 20055137 A NO20055137 A NO 20055137A NO 20055137 A NO20055137 A NO 20055137A NO 20055137 D0 NO20055137 D0 NO 20055137D0
Authority
NO
Norway
Prior art keywords
macrolide
treatment
combination
skin diseases
local anesthetic
Prior art date
Application number
NO20055137A
Other languages
English (en)
Other versions
NO20055137L (no
Inventor
Maximillan Grassberger
Stefan Hirsch
Nabila Sekkat
Carl-Martin Weiss
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of NO20055137D0 publication Critical patent/NO20055137D0/no
Publication of NO20055137L publication Critical patent/NO20055137L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20055137A 2003-04-04 2005-11-02 Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer NO20055137L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0307869.8A GB0307869D0 (en) 2003-04-04 2003-04-04 Pharmaceutical composition
PCT/EP2004/003515 WO2004087144A1 (en) 2003-04-04 2004-04-02 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases

Publications (2)

Publication Number Publication Date
NO20055137D0 true NO20055137D0 (no) 2005-11-02
NO20055137L NO20055137L (no) 2006-01-04

Family

ID=9956231

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055137A NO20055137L (no) 2003-04-04 2005-11-02 Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer

Country Status (13)

Country Link
US (1) US20060110448A1 (no)
EP (1) EP1613317A1 (no)
JP (1) JP2006522061A (no)
CN (1) CN1771036A (no)
AU (1) AU2004226823A1 (no)
BR (1) BRPI0409207A (no)
CA (1) CA2521261A1 (no)
GB (1) GB0307869D0 (no)
IS (1) IS8106A (no)
MX (1) MXPA05010709A (no)
NO (1) NO20055137L (no)
RS (1) RS20050752A (no)
WO (1) WO2004087144A1 (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9687455B2 (en) 2014-08-14 2017-06-27 John Daniel Dobak Sodium tetradecyl sulfate formulations for treatment of adipose tissue
US9351945B1 (en) 2015-02-27 2016-05-31 John Daniel Dobak, III Reduction of adipose tissue
KR102141441B1 (ko) * 2018-06-28 2020-08-05 이환석 무출혈 무통필름
CN108853312B (zh) * 2018-09-25 2021-04-16 陕西天宇制药有限公司 聚桂醇外用凝胶及其制备方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB766245A (en) * 1954-09-03 1957-01-16 Lilly Co Eli Therapeutic preparations containing erythromycin
HU194493B (en) * 1985-11-27 1988-02-29 Chinoin Gyogyszer Es Vegyeszet Process for preparing primycin-containing colloidal basic gel and compositions comprising the same
JPH08133979A (ja) * 1994-09-16 1996-05-28 Sando Yakuhin Kk 局所適用薬剤組成物
DE69525957T2 (de) * 1994-10-26 2002-11-14 Novartis Ag Verwendung eines ungesättigten Fettalkohols
CN1158258A (zh) * 1996-12-11 1997-09-03 李志辉 秦云创伤外用药
GB9723669D0 (en) * 1997-11-07 1998-01-07 Univ Aberdeen Skin penetration enhancing components
US6120792A (en) * 1998-04-29 2000-09-19 Juni; Jack E. Medicated skin patch and method for its use
JP2001288085A (ja) * 1999-07-21 2001-10-16 Shoei:Kk 乾癬の治療用又は予防用外用剤
JP2001288086A (ja) * 1999-07-21 2001-10-16 Shoei:Kk 皮膚疾患の治療用又は予防用外用剤
GB0003932D0 (en) * 2000-02-18 2000-04-12 Novartis Ag Pharmaceutical compositions
WO2002062353A1 (en) * 2001-02-05 2002-08-15 Marie Madeline Wharton Composition containing sucrafate and a topical anesthetic for human and animals and method of use thereof
RU2195279C1 (ru) * 2001-07-10 2002-12-27 Тульский государственный университет Способ лечения отморожений
CN1189193C (zh) * 2001-09-10 2005-02-16 黄家伶 烧伤药膏
CN1197576C (zh) * 2002-08-30 2005-04-20 孙万一 治疗性病疣的药物及其制备方法

Also Published As

Publication number Publication date
BRPI0409207A (pt) 2006-03-28
MXPA05010709A (es) 2005-12-12
EP1613317A1 (en) 2006-01-11
GB0307869D0 (en) 2003-05-14
US20060110448A1 (en) 2006-05-25
JP2006522061A (ja) 2006-09-28
IS8106A (is) 2005-10-31
NO20055137L (no) 2006-01-04
AU2004226823A1 (en) 2004-10-14
WO2004087144A1 (en) 2004-10-14
RS20050752A (sr) 2007-11-15
CA2521261A1 (en) 2004-10-14
CN1771036A (zh) 2006-05-10

Similar Documents

Publication Publication Date Title
DE60308293D1 (de) Blutbehandlungskathetereinrichtung
NO20034465D0 (no) Medisinsk pasientsimulator
DE60237823D1 (de) Medizinisches behandlungsinstrument
NO20041872L (no) Esterforbindelser og medisinsk anvendelse derav
HUS1500058I1 (hu) Benzoxazint tartalmazó gyógyszer-kombináció légúti betegségek kezelésére
DE60322451D1 (de) 4-Tetrazolyl-4-Phenylpiperidinderivate zur Schmerzbehandlung
FIU20060389U0 (fi) Luusairauksien hoito
NO20050569D0 (no) Fremgangsmate for behandling av alvorlig hjertesvikt og medikament for dette
IL172564A0 (en) N-PHENYL-PIPERAZINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF THE 5HT2c RECEPTOR ASSOCIATED DISEASES
ITMI20040571A1 (it) Apparecchiatura medicale per trattamenti intestinali e vaginali
IS7577A (is) Arómatísk súlfón og læknisfræðileg notkun þeirra
DE60319400D1 (de) Atemfähiges und mehrlagiges gewebe
ATE389742T1 (de) Gewebebehandlungsmittel
ATA13602003A (de) Therapeutisches behandlungsgerät
DK1553950T3 (da) Terapeutisk behandling
TWI347843B (en) Treatment of bacterial diseases of the respiratory organs
FI20021617A7 (fi) Diagnostisia ja terapeuttisia menetelmiä
EP1542654A4 (en) TREATMENT OF PHOTOTATIOOD AND ACTINIC DETERIORATION OF THE SKIN
EP1773882A4 (en) DIAGNOSTICS AND THERAPEUTICS FOR DISEASES ASSOCIATED WITH SIGLEC-6
NO20055137D0 (no) Kombinasjon av et makrolid og et lokalbedovelsesmiddel for behandling av hudsykdommer
LV12656B (lv) Arstniecibas lidzeklis un panemiens opija narkomanijas pacientu arstesanai
NO20031656L (no) Kombinasjon omfattende camptothecin og et stillbenderivat for behandling avcancer
EP1483407A4 (en) THERAPY AND DIAGNOSTIC PROCEDURES
AU2002364889A8 (en) Methods for diagnosis and treatment of diseases associated with altered expression of nrf2
GB0316940D0 (en) Treatment of skin and other medical conditions

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application